CTRI/2020/12/030094尚未招募未知
Experiences of patients and healthcare professionals during hospital-based source isolation for COVID-19.
Viola Dsouza0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Symptomatic COVID-19 positive patients who were enrolled in an isolation ward for over 5
- •daysâ?? stay and those who are above 18 years of age irrespective of gender, socioeconomic status,
- •comorbidities will be included. COVID -19 patients admitted in isolation wards will be included. Doctors working in COVID-19 isolation ward from the department of medicine will be included in the study.
排除标准
- •Asymptomatic patients, below 18 years and above 75 years will be excluded.
研究者
相似试验
尚未招募
不适用
Exploring health professional and patient perspectives of best practice care for people with chronic obstructive pulmonary disease, in the hospital and outpatient settingChronic Obstructive Pulmonary Diseaseadherence to COPD guidelinesviews of health professionals and consumersACTRN12618000641291The University of Adelaide15
招募中
不适用
Experience of Transfers to Rehabilitation ServicesPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationStroke - HaemorrhagicStroke - IschaemicstrokeACTRN12620000062921Auckland DHB400
已完成
不适用
Evaluation of patient experiences and perspectives of advance care planning in German general practicesAdvance planning of medical treatments for all patients with any health problem.DRKS00027368niversität Witten Herdecke8
尚未招募
不适用
Attitudes and experiences of medical and non-medical specialists in the northern district of Karlsruhe regarding the current legal situation of euthanasia in the Federal Republic of Germany. A cross-sectional study.Attitudes and experiences regarding active euthanasia.Attitudes and experiences regarding passive euthanasia.DRKS00012897Albert-Ludwigs-Universität Freiburg110
已完成
不适用
Expectations and experiences of patients, experts and physicians with the term immunotherapy” in cancervarious cancersC00-C97Malignant neoplasmsDRKS00011868niversitätsklinikum Heidelberg200
